| | In Bruce Nussbaum's 1990 book, ''Good Intentions: How Big Business And the Medical Establishment Are Corrupting the Fight Against AIDS'', | | In Bruce Nussbaum's 1990 book, ''Good Intentions: How Big Business And the Medical Establishment Are Corrupting the Fight Against AIDS'', |
| − | a large portion is about how [[Anthony Fauci]], head of the [[National Institutes of Health]] (NIH), used the federal bureaucracy to block all research on the development of a drug to treat AIDSin the late 1980s. Fauci pushed his patented Interleukin 2, a derivative of which became the highly toxic and controversial AZT.<ref>https://www.amazon.com/Good-Intentions-Business-Establishment-Corrupting/dp/0871133857</ref> | + | a large portion is about how [[Anthony Fauci]], head of the [[National Institutes of Health]] (NIH), used the federal bureaucracy to block all research on the development of a drug to treat AIDS in the late 1980s. Fauci pushed his patented Interleukin 2, a derivative of which became the highly toxic and controversial AZT.<ref>https://www.amazon.com/Good-Intentions-Business-Establishment-Corrupting/dp/0871133857</ref> |
| | In Celia Farber's 1989 expose on the scandal surrounding AZT, ''Sins of Omission'', newspapers across America banner headlined that AZT had been proven to be effective in antibody positive, [[asymptomatic]] patients even though one of the main concerns was that the drug should only be used as a last resort for critically ill AIDS patients because of the drugs extreme toxicity. Fauci, head of the National Institute of Health, was pushing to expand its use, and implied in a later interview that he either was inspired to do so due to [[ACT-UP]]'s terrorism, or otherwise used it as an excuse to do so.<ref>https://www.youtube.com/watch?v=wy3frBacd2k</ref> The [[FDA]]'s traditional concerns had been set aside. AZT was already being by an estimated 20,000 people in sixty countries. Not only had no new evidence dispelled the initial concerns regarding AZT's toxicity and safety, but the follow-up data that had been promised was ignored. The beneficial effects of the drug had been proven to be temporary. the toxicity however stayed the same. | | In Celia Farber's 1989 expose on the scandal surrounding AZT, ''Sins of Omission'', newspapers across America banner headlined that AZT had been proven to be effective in antibody positive, [[asymptomatic]] patients even though one of the main concerns was that the drug should only be used as a last resort for critically ill AIDS patients because of the drugs extreme toxicity. Fauci, head of the National Institute of Health, was pushing to expand its use, and implied in a later interview that he either was inspired to do so due to [[ACT-UP]]'s terrorism, or otherwise used it as an excuse to do so.<ref>https://www.youtube.com/watch?v=wy3frBacd2k</ref> The [[FDA]]'s traditional concerns had been set aside. AZT was already being by an estimated 20,000 people in sixty countries. Not only had no new evidence dispelled the initial concerns regarding AZT's toxicity and safety, but the follow-up data that had been promised was ignored. The beneficial effects of the drug had been proven to be temporary. the toxicity however stayed the same. |